News

Published on 24 Mar 2024 on Motley Fool via Yahoo Finance

1 Magnificent Dividend Stock to Buy and Hold


Article preview image

There are plenty of dividend stocks on the market. However, some raise their payouts irregularly, while others don't have businesses that look robust enough to support payout growth for a long time. Ideally, income-seeking investors want to avoid these situations. They prefer dividend-paying companies that can afford to raise their payouts regularly and aren't at risk of reducing or suspending their dividend programs.

Let's look at one stock that can give income-seekers precisely what they want: Swiss pharma giant Novartis (NYSE: NVS).

NYSE.NVS price evolution
SIX.NOVN price evolution

Want to become a better investor?

Start tracking your investments with Statfolio

Sign up for free
Related News
MorphoSys Says Novartis Deal Progressing Steadily Despite Safety Concerns Over Bone Marrow Cancer...

MorphoSys AG MOR is reportedly facing a burgeoning safety concern surrounding pelabresib, an expe...

Benzinga 29 Apr 2024

Novartis AG (NYSE:NVS) Q1 2024 Earnings Call Transcript

Novartis AG (NYSE:NVS) Q1 2024 Earnings Call Transcript April 23, 2024 Novartis AG isn’t one of t...

Insider Monkey via Yahoo Finance 24 Apr 2024

Stocks Rally On Weaker PMI Data, Tech Earnings Optimism, Dollar Falls: What's Driving Markets...

Stocks Rally On Weaker PMI Data, Tech Earnings Optimism, Dollar Falls: What's Driving Markets Tue...

Benzinga via Yahoo Finance 23 Apr 2024

FDA Approves Novartis' Lutathera As First Therapy For Pediatric Patients With Gastroenteropancreatic...

FDA Approves Novartis' Lutathera As First Therapy For Pediatric Patients With Gastroenteropancrea...

Benzinga via Yahoo Finance 23 Apr 2024

Novartis Surges After Forecast Boost Beats Expectations

Have a confidential tip for our reporters? Novartis AG raised its forecast as sales of blockbuste...

Bloomberg 23 Apr 2024

Novartis (NVS) Q1 Earnings, Sales Beat, Guidance Raised

Swiss pharma giant Novartis AG NVS reported better-than-expected results for the first quarter of...

Zacks via Yahoo Finance 23 Apr 2024

Novartis wins pediatric indication for Lutathera for rare cancer

Novartis' Lutathera has received FDA approval for children aged 12 and above with certain types o...

Seeking Alpha 23 Apr 2024

Why Novartis Stock Topped the Market on Tuesday

Scooting past analyst estimates for its latest quarter gave Novartis (NYSE: NVS) a lift on Tuesda...

Motley Fool via Yahoo Finance 23 Apr 2024

Novartis Ag (NVS) Q1 2024 Earnings Call Transcript

Image source: The Motley Fool. Novartis Ag (NYSE: NVS)Q1 2024 Earnings CallApr 23, 2024, 8:00 a.m...

Motley Fool via Yahoo Finance 23 Apr 2024

Tech advances are catalyzing the Health Care sector with improved investor sentiment -SSGA

The healthcare sector (XLV) has seen “the fruits of its labor” in higher earnings growth and help...

Seeking Alpha 19 Apr 2024